Since nesfatin-1 ́s actions are preserved in conditions of leptin resistance, the present findings render the NUCB2/nesfatin-1 system an appealing target for the development of novel therapeutical treatments towards obesity. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.